Acute, local effects of iontophoresed insulin and C-peptide on cutaneous microvascular function in Type 1 diabetes mellitus

Diabetic Medicine

Volumn 21, Issue 5, 2004, Pages 428-433

  Delaney, C ^a   Shaw, J ^a   Day, T ^b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

Author keywords

C peptide; Iontophoresis; Laser Doppler velocimetry; Type 1 diabete mellitus; Vasodilatation

Indexed keywords

ACETYLCHOLINE; C PEPTIDE; INSULIN; NEUTRAL INSULIN; NITROPRUSSIDE SODIUM; SODIUM CHLORIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; FEMALE; FOREARM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; IONTOPHORESIS; LASER DOPPLER FLOWMETRY; MALE; MICROVASCULATURE; SKIN BLOOD VESSEL; VASODILATATION;

ADULT; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; IONTOPHORESIS; LASER-DOPPLER FLOWMETRY; MALE; MICROCIRCULATION; MIDDLE AGED; PILOT PROJECTS; SKIN; VASODILATION;

EID: 2342537691     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2004.01167.x     Document Type: Article

References (25)

1. Steiner DF. On the role of the proinsulin C-peptide. Diabetes 1978; 27: 145-148.
2. Wahren J, Ekberg K, Johansson J, Henriksson M, Pramanik A, Johansson BL et al. Role of C-peptide in human physiology. Am J Physiol Endocrinol Metab 2000; 278: E759-768.
3. Gangarosa LP, Park NH, Fong BC, Scott DF, Hill JM. Conductivity of drugs used for iontophoresis. J Pharm Sci 1978; 67: 1439-1443.
4. Westerman RA, Lindblad LE, Wajnblum D, Roberts RG, Delaney CA. Confounding factors in non-invasive tests of neurovascular function in diabetes mellitus. Clin Exp Neurol 1992; 29: 149-160.
5. Westerman RA, Widdop RE, Hannaford J, Low A, Roberts RG, Kent P et al. Laser Doppler velocimetry in the measurement of neurovascular function. Australas Phys Eng Sci Med 1988; 11: 53-66.
6. Hingorani AD, Vallance PJ. Endothelial nitric oxide. In Webb DJ ed. Vascular Endothelium in Human Physiology and Pathophysiology. Amsterdam: Harwood Academic, 2000; 3-28.
7. Kubli S, Waeber B, Dalle-Ave A, Feihl F. Reproducibility of laser Doppler imaging of skin blood flow as a tool to assess endothelial function. J Cardiovasc Pharmacol 2000; 36: 640-648.
8. Westerman R, Widdop R, Low A, Hannaford J, Kozak W, Zimmet P. Non-invasive tests of neurovascular function: reduced axon reflex responses in diabetes mellitus of man and streptozotocin-induced diabetes of the rat. Diabetes Res Clin Pract 1988; 5: 49-54.
9. Katz A, Ekberg K, Johansson BL, Wahren J. Diminished skin blood flow in Type I diabetes: evidence for non-endothelium-dependent dysfunction. Clin Sci (Lond) 2001; 101: 59-64.
10. Yki-Jarvinen H, Utriainen T. Insulin-induced vasodilatation: physiology or pharmacology? Diabetologia 1998; 41: 369-379.
11. Kari B. Control of blood glucose levels in alloxan-diabetic rabbits by iontophoresis of insulin. Diabetes 1986; 35: 217-221.
12. Delaney CA, Murchie KJ, Westerman RA, de Courten MP. Rapid actions of insulin on sensory nerve function. Neuroreport 1998; 9: 2775-2779.
13. +-ATPase activity in diabetes mellitus type I. Clin Sci (Lond) 2000; 98: 283-290.
14. Grossmann M, Jamieson MJ, Kellogg DL Jr, Kosiba WA, Pergola PE, Crandall CG et al. The effect of iontophoresis on the cutaneous vasculature: evidence for current-induced hyperemia. Microvasc Res 1995; 50: 444-452.
15. Forst T, Kunt T, Pfutzner A, Beyer J, Wahren J. New aspects on biological activity of C-peptide in IDDM patients. Exp Clin Endocrinol Diabetes 1998; 106: 270-276.
16. Feleton M, Vanhoutte PM. Endothelium-derived hyperploarizing factor. In Webb DJ ed. Vascular Endothelium in Human Physiology and Pathophysiology. Amsterdam: Harwood Academic, 2000; 75-92.
17. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 1994; 94: 2511-2515.
18. Tack CJ, Lutterman JA, Vervoort G, Thien T, Smits P. Activation of the sodium-potassium pump contributes to insulin-induced vasodilation in humans. Hypertension 1996; 28: 426-432.
19. Tooke JE, Morris SJ, Shore AC. Microvascular functional abnormalities in diabetes: the role of the endothelium. Diabetes Res Clin Pract 1996; 31: S127-132.
20. Forst T, Kunt T, Pohlmann T, Goitom K, Engelbach M, Beyer J et al. Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus. J Clin Invest 1998; 101: 2036-2041.
21. Johansson BL, Sjoberg S, Wahren J. The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia 1992; 35: 121-128.
22. Johansson BL, Linde B, Wahren J. Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients. Diabetologia 1992; 35: 1151-1158.
23. Kunt T, Schneider S, Pfutzner A, Goitum K, Engelbach M, Schauf B et al. The effect of human proinsulin C-peptide on erythrocyte deformability in patients with Type I diabetes mellitus. Diabetologia 1999; 42: 465-471.
24. Rigler R, Pramanik A, Jonasson P, Kratz G, Jansson OT, Nygren P et al. Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci USA 1999; 96: 13318-13323.
25. Wahren J, Johansson BL, Wallberg-Henriksson H, Linde B, Fernqvist-Forbes E, Zierath JR. C-peptide revisited - new physiological effects and therapeutic implications. J Intern Med 1996; 240: 115-124.